Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

TRAW

Traws Pharma, Inc.

Pharmaceutical Preparations · SIC 2834CIK 1130598Held by 2 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$3.0M
Net Income FY2025
$9.0M
EPS (Basic, as reported)
$0.83
Net Margin FY2025
328.7%
ROE FY2025
-1457.9%
Total Equity
$(1.0M)
Shares Out
15M
Business description

Traws Pharma, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2011–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 6 → 3 -7.4% CAGR
Fiscal yearFY2016FY2017FY2018FY2019FY2020⚑FY2021FY2022FY2023⚑FY2024⚑FY2025
Revenue6112000003
Research & development(20)(19)(17)(16)(17)(7)(11)(11)——
General & administrative(9)(7)(8)(8)(8)(9)(8)(9)(12)(9)
Total operating expenses(29)(27)(25)(24)(25)(17)(20)(21)(143)(21)
Operating income(24)(26)(23)(22)(25)(16)(20)(20)(142)(18)
Interest expense——————————
Interest & investment income——————1110
Other income (expense), net0010001100
Pre-tax income(20)(24)(21)(21)(25)(16)(19)(19)(167)9
Income tax expense00000—————
Net income(20)(24)(21)(22)(25)(16)(19)(19)(167)9
EPS — basic————($2.17)($0.96)($0.91)($0.90)($35.21)$0.83
EPS — diluted————($2.17)($0.96)($0.91)($0.90)($35.21)$0.82
Shares outstanding — basic (M)————1217212128
Shares outstanding — diluted (M)————1217212128

Showing the latest 10 of 15 fiscal years.

  • ⚑ Weighted-average shares changed ×1.42 between FY2020 and FY2021 — a large issuance or reduction. Per-share figures on either side are as reported and not adjusted.
  • ⚑ Weighted-average shares changed ÷10.00 between FY2023 and FY2024 — likely a reverse split. Per-share figures on either side are as reported and not adjusted.
  • ⚑ Weighted-average shares changed ×4.00 between FY2024 and FY2025 — likely a stock split. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.